These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 2523681
1. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. Gross NJ, Petty TL, Friedman M, Skorodin MS, Silvers GW, Donohue JF. Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681 [Abstract] [Full Text] [Related]
2. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease. Ikeda A, Nishimura K, Koyama H, Izumi T. Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652 [Abstract] [Full Text] [Related]
3. Studies of ipratropium bromide and fenoterol administered by metered-dose inhaler and aerosolized solution. Marlin GE. Respiration; 1986 Jan; 50 Suppl 2():290-3. PubMed ID: 2951824 [Abstract] [Full Text] [Related]
4. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD? Eiser NM, Phillips C, Wooler PA. Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505 [Abstract] [Full Text] [Related]
5. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ. Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [Abstract] [Full Text] [Related]
6. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease. Rammeloo RH, Luursema PB, Sips AP, Beumer HM, Wald FD, Cornelissen PJ. Respiration; 1992 Sep; 59(6):322-6. PubMed ID: 1488568 [Abstract] [Full Text] [Related]
7. A placebo-controlled comparison between the bronchodilatory effects of ipratropium bromide inhaled as a dry powder and by metered dose inhaler in chronic obstructive pulmonary disease. Gimeno F, van Veenen R, Berg WC, Steenhuis EJ. Ann Allergy; 1988 Nov; 61(5):341-3. PubMed ID: 2973269 [Abstract] [Full Text] [Related]
8. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease. Ikeda A, Nishimura K, Koyama H, Tsukino M, Mishima M, Izumi T. Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369 [Abstract] [Full Text] [Related]
18. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease. Friedman M. Am J Med; 1996 Jan 29; 100(1A):30S-39S. PubMed ID: 8610715 [Abstract] [Full Text] [Related]
19. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients. Cuvelier A, Muir JF, Benhamou D, Weitzenblum E, Zuck P, Delacenserie R, Taytard A, Iacono P. Respir Care; 2002 Feb 29; 47(2):159-66. PubMed ID: 11812272 [Abstract] [Full Text] [Related]
20. Comparison of the bronchodilator efficacy of nebulized pirenzepine and ipratropium bromide in patients with airway obstructive lung disease. Ceyhan B, Celikel T, Simsir S, Kandemir B. Int J Clin Pharmacol Ther Toxicol; 1993 Oct 29; 31(10):510-3. PubMed ID: 8262690 [Abstract] [Full Text] [Related] Page: [Next] [New Search]